Efficacy and safety of pemafibrate administration in patients with dyslipidemia: a systematic review and meta-analysis

Using a meta-analysis of randomized controlled trials (RCTs), this study aimed to investigate the efficacy and safety of pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator, i...

Source: Cardiovascular Diabetology - March 21, 2019 Category: Cardiology Authors: Satoshi Ida, Ryutaro Kaneko and Kazuya Murata Tags: Original investigation Source Type: research